Recent

% | $
Quotes you view appear here for quick access.

công ty Interleukin Genetics Message Board

  • smallcapsking smallcapsking Dec 1, 2011 8:40 AM Flag

    Accumulate why you Can - Zacks has $1.60 price target

    I know there is very little volume on this stock and it seems that everyone is asleep. Let me tell you why I am buying this stock and have been over the last year. Alticor, the company that owns Interleukin, Amway and Pyxis the funding partner of Interleukin who holds 59.78% of ILIU stock. There are approx 11.5 mil shares held today in the market. At the end of the day Alticor wants ILIU to succeed so they can offer products within the Amway system or with direct selling agreements.

    The PST Genetic Test is the area I have the most hope. When the Michigan study is done Q1 2012 and results are in by mid 2012 this could be a home run if a Delta Dental sees the value of making this test reimbursable to dentists. Don't forget ILIU has two similar PST tests being done in China that will be completed in mid 2012 as well.

    If this PST test is as promising as I hope, ILIU will be first to market with a world full of opportunity.

    I am not as focused on other aspects of the company as I am with the PST test and believe this is enough to get you hopeful this PST is successful. Zachs has a $1.60 price target, which sounds just fine. I don't think anyone can make and estimate at this time if this PST test is determined to be a saving grace for dentists and patients on how best to conduct oral health.

    I will keep my fingers crossed that the 4,000 patient Michigan study works and Delta Dental sees the value. If this happens the stock will take care of itself and hopefully get off these pink sheets.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
ILIU
0.140.00(+2.19%)Jul 2 3:56 PMEDT